SHINE trial on shorter treatment for children with minimal TB

TB treatment can be shortened from six to four months in 80% of children.

Read More →

Landmark TB trial identifies shorter-course treatment regimen

Landmark phase III trial shows that the shorter regimen containing rifapentine and moxifloxacin can safely and effectively cure TB in four months.

Read More →

Progress towards achieving global TB targets

UN Secretary-General outlines priority recommendations to accelerate the TB response and reach targets.

Read More →

WHO: Global TB progress at risk

Global TB Report 2020: Access to TB services remains a challenge; global targets for prevention and treatment will likely be missed without urgent action and investments.

Read More →

Policy brief: COVID-19 – the new reality of Ending Tuberculosis

A document, released by the TB Europe Coalition, in commemoration of the second anniversary of the signing of the UN Political Declaration on TB.

Read More →

TAG policy brief: Advancing Access through Market Interventions

Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down

Read More →

Public investment in bedaquiline up to five-fold that of Johnson & Johnson

PLOS ONE publishes TAG’s rigorous, peer-reviewed calculation of investments in the development of this life-saving TB medicine.

Read More →

TAG policy brief: TB Research Investments Provide Returns in Combating Both TB and COVID-19

Sustained and expanded financing is needed to safeguard TB research against COVID-19–related disruptions and improve global epidemic preparedness.

Read More →

Declaration of the Rights of People Affected by TB now available in Arabic

The Declaration was launched in May 2019 by TBpeople in partnership with the Stop TB Partnership.

Read More →

Global Strategy for TB Research and Innovation adopted

Member States of the World Health Organization adopt the Global Strategy for TB Research and Innovation at 73rd World Health Assembly.

Read More →

Page 1 of 106 · Total posts: 10

1 2 Last→